2025 ESMO ASIA2025年欧洲肿瘤内科学会亚洲年会(ESMO ASIA 2025)将于2025年12月5日~12月7日在新加坡召开。君实生物多项创新产品最新临床研究结果入选本届大会,涉及抗体偶联药物(ADC)、双抗等新型疗法。其中,抗Claudin 18.2(CLDN18.2)ADC药物JS107入选最新突破摘要(LBA)、将以口头报告的形式公布用于晚期实体瘤的I期临床研究更新数据(...
Source Link2025 ESMO ASIA2025年欧洲肿瘤内科学会亚洲年会(ESMO ASIA 2025)将于2025年12月5日~12月7日在新加坡召开。君实生物多项创新产品最新临床研究结果入选本届大会,涉及抗体偶联药物(ADC)、双抗等新型疗法。其中,抗Claudin 18.2(CLDN18.2)ADC药物JS107入选最新突破摘要(LBA)、将以口头报告的形式公布用于晚期实体瘤的I期临床研究更新数据(...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.